Bausch Health Companies | VRX - Net Income

Stock Price
7.11
Daily Change
0.23 3.34%
Monthly
-16.45%
Yearly
-29.04%
Q1 Forecast
6.65

Bausch Health Companies reported $-112M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Amgen USD 1.33B 1.88B Dec/2025
ANI Pharmaceuticals USD 32.35M 6.08M Dec/2025
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Bausch Health Companies USD -112M 291M Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Canopy Growth CAD -1.64M 39.89M Sep/2025
Corcept Therapeutics USD 24.29M 4.62M Dec/2025
Danaher USD 1.2B 289M Dec/2025
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Novo Nordisk DKK 26.89B 388M Dec/2025
Pacira USD 1.64M 3.8M Dec/2025
Perrigo USD -1.42B 1.43B Dec/2025
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Vertex Pharmaceuticals USD 1.19B 108.2M Dec/2025
Zoetis USD 603M 118M Dec/2025